Drug details

Seebri Neohaler (glycopyrrolate inhalation powder, for oral inhalation use)

type of COPD Agents, Anticholinergics, Respiratory

Seebri Neohaler (glycopyrrolate) inhalation powder is an anticholinergic indicated for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).

The drug is often used to treat Chronic obstructive pulmonary disease .

This drug may have the following side effects:

• upper respiratory tract infection,
• sore throat,
• runny or stuffy nose,
• back pain
• high blood pressure (hypertension), and

The following drugs are related to Seebri Neohaler, either as a replacement or used together:

• Ventolin HFA (albuterol sulfate inhalation aerosol)
• Azmacort (triamcinolone acetonide (inhalation aerosol))
• Pulmicort Turbuhaler (budesonide)
• Symbicort Aerosphere (budesonide and formoterol fumarate inhalation aerosol)
• Pulmicort Flexhaler (budesonide inhalation powder)
• Pulmicort Respules (budesonide inhalation suspension)
• Combivent (ipratropium bromide and albuterol sulfate)
• Combivent Respimat (ipratropium bromide and albuterol)
• Ketek (telithromycin)
• Xopenex (levalbuterol)
• Xopenex HFA (levalbuterol tartrate inhalation aerosol)
• Yupelri (revefenacin inhalation solution)
• Serevent Diskus (salmeterol xinafoate)
• Stiolto Respimat (tiotropium bromide and olodaterol)